Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Ben Yan Zou"'
Autor:
Xiao‐Li Wei, Chao Ren, Feng‐Hua Wang, Yang Zhang, Hong‐Yun Zhao, Ben‐Yan Zou, Zhi‐Qiang Wang, Miao‐Zhen Qiu, Dong‐Sheng Zhang, Hui‐Yan Luo, Feng Wang, Sheng Yao, Rui‐Hua Xu
Publikováno v:
Cancer Communications, Vol 40, Iss 8, Pp 345-354 (2020)
Abstract Background Several programmed cell death ligand 1 (PD‐L1)/programmed cell death protein 1 (PD‐1) antibodies have been approved for cancer treatment worldwide. Their pharmacokinetic and pharmacodynamic characteristics have been reported m
Externí odkaz:
https://doaj.org/article/8ce01e25a806447a911986d71c98652a
Autor:
Xiao-Li Wei, Yang Zhang, Hong-Yun Zhao, Wen-Feng Fang, Hui-Yan Luo, Miao-Zhen Qiu, Ming-Ming He, Ben-Yan Zou, Jie Xie, Chun-Lei Jin, Xian-Feng Zhou, Feng Wang, Feng-Hua Wang, Yu-Hong Li, Zhi-Qiang Wang, Rui-Hua Xu
Publikováno v:
The oncologist.
Background SHR7390 is a novel, selective MEK1/2 inhibitor. Here, we report results from two phase I trials conducted to evaluate the tolerability, safety and antitumor activity of SHR7390 monotherapy for advanced solid tumors and SHR7390 plus camreli
Publikováno v:
Journal of Analytical Methods in Chemistry, Vol 2014 (2014)
Photocyanine is a novel anticancer drug. Its pharmacokinetic study in cancer patients is therefore very important for choosing doses, and dosing intervals in clinical application. A rapid, selective and sensitive high-performance liquid chromatograph
Externí odkaz:
https://doaj.org/article/396ad355f6f14aa392e7072ba0b4a10a
Autor:
Yu Wang, Xi Wen Bi, Su Li, Peng Sun, Wen Qi Jiang, Hang Yang, Ben Yan Zou, Pan Pan Liu, Jing Zhan, Zhi Ming Li, Yi Xia
Publikováno v:
Oncotarget
// Hang Yang 1, 2, * , Yu Wang 1, 2, * , Jing Zhan 1, 3 , Yi Xia 1, 2 , Peng Sun 1, 2 , Xi-Wen Bi 1, 2 , Pan-Pan Liu 1, 2 , Zhi-Ming Li 1, 2 , Su Li 1, 3 , Ben-Yan Zou 1, 4 , Wen-Qi Jiang 1, 2 1 Sun Yat-sen University Cancer Center, State Key Laborat
Autor:
Xuan Wu, Yuanyuan Zhao, Jianwei Zhang, Li Zhang, Liping Zhao, Yan Huang, Jing Zhang, Cong Xue, Zhi Huang Hu, Ying Ma, Y. Ma, Chen Lu Wei, Jun Ling Liu, Li Kun Chen, Hong Yun Zhao, Ben Yan Zou, Fei Xu
Publikováno v:
Future Oncology. 10:2579-2591
ABSTRACT Aim: To confirm whether the aflibercept dose, plus docetaxel, in western study TCD6120 is appropriate for Chinese patients with nasopharyngeal carcinoma (NPC) and other solid tumors. Materials & methods: To assess dose-limiting toxicity of e
Autor:
Yan Huang, Ben Yan Zou, Li Zhang, Rui Zhen Gao, Fei Xu, Yuanyuan Zhao, Ying Tian, Y. Ma, Yun Peng Yang
Publikováno v:
Chinese Journal of Cancer
To improve cancer pain management, the Medical Oncology Department of Sun Yat-sen University Cancer Center (SYSUCC) launched the Good Pain Management (GPM) Ward Program, which has been recognized by the Chinese Ministry of Health and promoted through
Publikováno v:
Journal of Chromatographic Science. 52:766-772
Photocyanine, a novel amphoteric phthalocyanine drug, showed favorable anticancer activity in vivo. Pharmacokinetic study in cancer patients is an important component in dose administration choice. In this study, a rapid, sensitive analytical method
Autor:
Wen Qi Jiang, Yin Guo, Ben Yan Zou, Su Li, Zhong Zhen Guan, Jing Zhan, Xu Qing Yang, He Huang, Hai Liao
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 51:96-105
Translational relevance: Di- cycloplatin (DCP) is a novel super molecule composed of carboplatin (CBP) and 1,1-cy- clobutane dicarboxylate (CBDCA) joined by a strong hydrogen bond. The solubility and stability of platinum complexes have a direct bear
Autor:
Ben Yan Zou, Wen Qi Jiang, Yi Xia, Jia Jia Huang, Hui Qiang Huang, Ying Jie Zhu, Zhi Ming Li, Jian Sun, Tong Yu Lin
Publikováno v:
Annals of Hematology. 91:1265-1270
Upper aerodigestive tract natural killer (NK)/T-cell lymphoma (UNKTL) is the most common type of extranodal NK/T-cell lymphoma, nasal type. Serum beta2-microglobulin (β2-M) was found to be a predictor in some subtypes of B-cell lymphoma. However, it
Autor:
Tong Yu Lin, Cheng Cheng Guo, Xing Gui Chen, Rui Qing Cai, Ying Tian, He Huang, Chao Yong Liang, Ben Yan Zou, Yao Ling Gong
Publikováno v:
Chinese Journal of Cancer
Angioimmunoblastic T-cell lymphoma (AITL) is a rare, distinct subtype of peripheral T-cell lymphoma, possessing an aggressive course and poor prognosis with no standard therapy. Twelve patients who have failed at least two initial CHOP or CHOP-like r